Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-14 · accession 0001193125-26-111511 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Colleran David | EVP, GC, Corp Sec | M - OptEx | — | +15.8K | 62.5K | +34% | — |
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Colleran David | EVP, GC, Corp Sec | F - Tax | $14.20 | -6,061 | 67.6K | -8% | -$86.1K |
| D | 2026-03-17 | 2026-03-14 | ANIK | Colleran David | EVP, GC, Corp Sec | A - Grant | $0.00 | +4,694 | 67.2K | +8% | $0 |
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | -15.8K | 6,448 | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 6,449 | — | 69,463 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2026-03-14 | F | D | 4,168 | $14.20 | 63,014 | D | — | — | (F3) Reflects an aggregate of 4,694 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026. |
| 3 | Common | Common Stock | 2026-03-14 | A | A | 4,694 | $0.00 | 67,182 | D | — | — | (F2) On March 14, 2025, the Reporting Person was granted 14,082 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award. |
| 4 | Common | Common Stock | 2026-03-14 | M | A | 9,388 | — | 62,488 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. |
| 5 | Common | Common Stock | 2026-03-15 | F | D | 1,893 | $14.20 | 67,570 | D | — | — | (F4) Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026. |
| 6 | Derivative | Restricted Stock Unit | 2026-03-14 | M | D | 9,388 | $0.00 | 18,777 | D | — · — to — | 9,388 Common Stock | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F5) On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award. |
| 7 | Derivative | Restricted Stock Unit | 2026-03-15 | M | D | 6,449 | $0.00 | 6,448 | D | — · — to — | 6,449 Common Stock | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F6) On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award. |